GlaxoSmithKline (GSK) has appointed Iain Mackay as Chief Financial Officer. He has also been appointed as an executive director to the GSK board. Mackay will join the company on 14 January 2019.
Mackay joins GSK from the global bank HSBC, where he has been Group Finance Director for the last 8 years. GSK announced in May that the company’s CFO, Simon Dingemans, is to retire from the company in May 2019.
A chartered accountant, Mackay has worked in Asia, the US and Europe and before HSBC was at General Electric, Schlumberger Dowell and Price Waterhouse. He is a trustee of the British Heart Foundation and a member of the Court of the University of Aberdeen.
Emma Walmsley, CEO at GSK said: “I am delighted to welcome Iain to GSK. As a proven CFO of a complex, regulated global organisation, he brings tremendous finance experience and will be a great addition to the team."
She continued: "He is a strong leader with a track record of driving cost, cash and capital allocation discipline to deliver strategy. These capabilities will be vital as we continue to implement our Innovation, Performance and Trust priorities for the benefit of patients and shareholders.”
Simon Dingemans will continue to be accountable as CFO for GSK’s financial governance until March 2019.
